ATP6AP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.799600E-01
Normal-vs-Stage2
7.993600E-01
Normal-vs-Stage3
6.357200E-01
Normal-vs-Stage4
7.848800E-01
Stage1-vs-Stage2
2.459200E-01
Stage1-vs-Stage3
3.106000E-01
Stage1-vs-Stage4
9.558600E-01
Stage2-vs-Stage3
6.050000E-01
Stage2-vs-Stage4
3.905600E-01
Stage3-vs-Stage4
4.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.720600E-01
Normal-vs-AfricanAmerican
8.871400E-01
Normal-vs-Asian
4.240000E-01
Caucasian-vs-AfricanAmerican
9.153200E-01
Caucasian-vs-Asian
7.932100E-02
AfricanAmerican-vs-Asian
1.753450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.829000E-01
Normal-vs-Female
8.376800E-01
Male-vs-Female
1.639650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.597800E-01
Normal-vs-Age(41-60Yrs)
6.291200E-01
Normal-vs-Age(61-80Yrs)
7.827800E-01
Normal-vs-Age(81-100Yrs)
4.366200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.674200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.541400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.019600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.655600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.422200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.648800E-01
Normal-vs-Daily Drinker
8.127600E-01
Normal-vs-Weekly Drinker
7.060000E-01
Normal-vs-Occasional Drinker
5.447000E-01
Normal-vs-Social Drinker
7.975800E-01
Non Drinker-vs-Daily Drinker
8.215700E-02
Non Drinker-vs-Weekly Drinker
3.488400E-01
Non Drinker-vs-Occasional Drinker
1.056220E-02
Non Drinker-vs-Social Drinker
2.311200E-01
Daily Drinker-vs-Weekly Drinker
2.899800E-01
Daily Drinker-vs-Occasional Drinker
5.973400E-01
Daily Drinker-vs-Social Drinker
8.117800E-01
Weekly Drinker-vs-Occasional Drinker
8.850000E-02
Weekly Drinker-vs-Social Drinker
3.973600E-01
Occasional Drinker-vs-Social Drinker
9.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.226600E-01
Normal-vs-Grade 2
7.824000E-01
Normal-vs-Grade 3
7.898600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.006200E-01
Grade 1-vs-Grade 3
2.884200E-01
Grade 1-vs-Grade 4
5.226600E-01
Grade 2-vs-Grade 3
8.853400E-01
Grade 2-vs-Grade 4
7.824000E-01
Grade 3-vs-Grade 4
7.898600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.547400E-01
Normal-vs-NonDiabetic
9.310600E-01
Diabetic-vs-NonDiabetic
2.148200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.918000E-01
Normal-vs-NoPancreatitis
9.917000E-01
Pancreatitis-vs-NoPancreatitis
7.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.211200E-01
Normal-vs-N1
8.756000E-01
N0-vs-N1
4.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.809600E-01
Normal-vs-TP53-NonMutant
9.517400E-01
TP53-Mutant-vs-TP53-NonMutant
9.095200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
